SPTD: Observational Study of the Evaluation of Post Traumatic Stress Post Stroke
Study Details
Study Description
Brief Summary
This prospective, observational, multicentre study evaluates the existence of Post-traumatic stress disorder following a stroke at 3 and 6 months after the management of the patient.
Questionnaires will be used to assess the presence of stroke post traumatic disorder.
The evaluation of stroke post traumatic disorder would allow to underline the importance of the awareness of the care teams in the the screening of these disorders and to evaluate if the Post-traumatic Stress Disorder Checklist Scale (PCL5) is an effective screening tool.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 months after stroke [at time of inclusion (3 months after stroke)]
Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 months after stroke. This evaluation will be made by completion of PCL-5 questionnaire (Post-traumatic stress disorder checklist version DSM-5 (DSM:Diagnostic and Statistical Manuel of Mental Disorders)). A PCL-5 positive score will be an indicator of post-traumatic stress disorder correlated with stroke.
Secondary Outcome Measures
- Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 and at 6 months [at time of inclusion (3 months after stroke) and 6 months after stroke (study participation duration for patient: 3 months)]
Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 and at 6 months. This evaluation will be made by completion of PCL-5 questionnaire (Post-traumatic stress disorder checklist version DSM-5). A PCL-5 positive score will be an indicator of post-traumatic stress disorder correlated with stroke. Two timepoint: 3 months and 6 months after stroke.
- Evaluate the number of patients presenting a depressive state at 3 months [at time of inclusion (3 months after stroke)]
Evaluate the number of patients presenting a depressive state at 3 months after stroke. This evaluation was done by completion of HAD (Hospital Anxiety and Depression scale) questionnaire. A score between 8 and 10 will identify a doubtful depressive symptomatology and a score Superior to 11 will identify a certain depressive symptomatology.
- Evaluate the number of patients under antidepressant or anxiolytics treatment before the stroke [at time of inclusion (3 months after stroke)]
The evaluation of the number of patients under antidepressant or anxiolytics treatment before the stroke will be made by the collection of previous treatments of the patient.
- Evaluate the PCL-5 questionnaire as a screening tool of the stroke post traumatic disorder [at time of inclusion (3 months after stroke) and 6 months after stroke (study participation duration for patient: 3 months)]
Evaluate the PCL-5 questionnaire as a screening tool of the stroke post traumatic disorder by completion of PCL-5 questionnaire at two timepoint (3 and 6 months post-stroke). The presence of Post-traumatic Stress Disorder will be defined by threshold value of 38 as the total score on the PCL-5 questionnaire.
- Evaluate the traumatic history of the patient before the occurrence of the stroke [at time of inclusion (3 months after stroke)]
Evaluate the number of patients presenting a depressive state at 3 months after stroke. This evaluation was done by completion of Trauma History Questionnaire (THQ).
- Evaluate the existence of a peritraumatic dissociation at the time of the occurrence of the stroke [at time of inclusion (3 months after stroke)]
Evaluate the number of patients presenting a depressive state at 3 months after stroke. This evaluation was done by completion of PDEQ (Peritraumatic Dissociative Experience Questionnaire).
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient age > 18years old
-
Patient registered with a social security scheme
-
Patient who was given a written information and who gave his/her non-opposition
-
Patient who was hospitalized with a diagnosis of stroke in the neurology department and oriented to the post-stroke consultation (3 months after the hospital discharge) or un the follow-up care and readaptation department of hospital center of Dax or Mont de Marsan
Exclusion Criteria:
-
Patient with a serious disability sequelae (mRS>3),
-
Patient without enough level of proficiency in the French language,
-
Patient with neurocognitive and neurocognitive disorder diagnosed,
-
Patient with history of significant psychiatric disorders diagnosed,
-
Patient with seve aphasia
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | centre hospitalier Dax | Dax | France | 40100 |
Sponsors and Collaborators
- Ch Mont de Marsan
Investigators
- Principal Investigator: Harold PERDIGNON, CH de Dax
- Study Director: Francine CLEMENTI, MD, CH de Dax
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2019-A01962-55